Potentiation of cellular antioxidant capacity by Bcl-2: Implications for its antiapoptotic function

Biochemical Pharmacology

Volumn 66, Issue 8, 2003, Pages 1371-1379

  Jang, Jung Hee ^a   Surh, Young Joon ^a  

^a Seoul National University   (South Korea)

Author keywords

Bcl 2 homology domain 4; BH4; CAT; Catalase; GCL; Glutamate cysteine ligase; Glutathione peroxidase; Glutathione reductase; GPx; GR; I B kinase; IKK; MAPK; NF B; Nuclear factor B; Reactive oxygen intermediates; ROIs; SOD; Superoxide dismutase

Indexed keywords

3 NITROPROPIONIC ACID; AMYLOID BETA PROTEIN; ANTIOXIDANT; ANTISENSE OLIGONUCLEOTIDE; BETA LAPACHONE; CATALASE; CELL ENZYME; DEXAMETHASONE; DIAZIQUONE; DOXORUBICIN; GLUTATHIONE; GLUTATHIONE REDUCTASE; HYDROGEN PEROXIDE; HYDROXYL RADICAL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MEMBRANE PROTEIN; MENADIONE; MITOGEN ACTIVATED PROTEIN KINASE; OXIDOPAMINE; PARAQUAT; PARTHENOLIDE; PEROXIDE; PROTEIN BCL 2; PYRROLIDINE DITHIOCARBAMATE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; THIOREDOXIN REDUCTASE; TRANSFORMING GROWTH FACTOR BETA;

ANTIOXIDANT ACTIVITY; APOPTOSIS; CANCER; CARBONYLATION; CELL DEATH; CELL LEVEL; CELL PROTECTION; CELL SURVIVAL; CONFERENCE PAPER; DEGENERATIVE DISEASE; DIABETES MELLITUS; DNA MODIFICATION; DRUG MECHANISM; ENZYME REGULATION; EXPRESSION VECTOR; GENE CONTROL; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE OVEREXPRESSION; GENE TARGETING; GENETIC TRANSFECTION; GLUTATHIONE METABOLISM; HUMAN; LIPID PEROXIDATION; MITOCHONDRIAL MEMBRANE; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; UPREGULATION; ANIMAL; METABOLISM; PHYSIOLOGY; REVIEW;

ANIMALS; ANTIOXIDANTS; APOPTOSIS; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; OXIDATIVE STRESS; PROTO-ONCOGENE PROTEINS C-BCL-2; UP-REGULATION;

EID: 0642345209     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(03)00487-8     Document Type: Conference Paper

References (72)

1. Jenner P. Oxidative damage in neurodegenerative disease. Lancet. 344:1994;796-798.
2. Carmody R.J., Cotter T.G. Signalling apoptosis: a radical approach. Redox Rep. 6:2001;77-90.
3. Kim H.-J., So Y.J., Jang J.-H., Lee J.-S., Oh Y.J., Surh Y.-J. Differential cell death induced by salsolinol with and without copper: possible role of reactive oxygen species. Mol. Pharmacol. 60:2001;440-449.
4. Jang H.-H., Surh Y.-J. Protective effects of resveratrol on β-amyloid-induced oxidative PC12 cell death. Free Radic. Biol. Med. 34:2003;1100-1110.
5. Cummings M.C., Winterford C.M., Walker N.I. Apoptosis. Am. J. Surg. Pathol. 21:1997;88-101.
6. Zhong L.T., Sarafian T., Kane D.J., Charles A.C., Mah S.P., Edwards R.H., Bredesen D.E. bcl-2 inhibits death of central neural cells induced by multiple agents. Proc. Natl. Acad. Sci. U.S.A. 90:1993;4533-4537.
7. Blum D., Torch S., Nissou M.-F., Verna J.-M. 6-Hydroxydopamine-induced nuclear factor-kappaB activation in PC12 cells. Biochem. Pharmacol. 62:2001;473-481.
8. Hockenbery D.M., Oltvai Z.N., Yin X., Milliman C., Korsmeyer S.J. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell. 75:1993;241-251.
9. Kane D.J., Sarafian T.A., Anton R., Hahn H., Gralla E.B., Valentine J.S., Ord T., Bredesen D.E. Bcl-2 inhibition of neural death: decreased generation of reactive oxygen species. Science. 262:1993;274-277.
10. Amstad P.A., Liu H., Ichimiya M., Berezesky I.K., Trump B.F., Buhimschi I.A., Gutierrez P.L. BCL-2 is involved in preventing oxidant-induced cell death and in decreasing oxygen radical production. Redox Rep. 6:2001;351-362.
11. Bogdanov M.B., Ferrante R.J., Mueller G., Ramos L.E., Martinou J.C., Beal M.F. Oxidative stress is attenuated in mice overexpressing BCL-2. Neurosci. Lett. 262:1999;33-36.
12. Huang Y.L., Chou C.K. Bcl-2 blocks apoptotic signal of transforming growth factor-beta in human hepatoma cells. J. Biomed. Sci. 5:1998;185-191.
13. Chau Y.P., Shiah S.G., Don M.J., Kuo M.L. Involvement of hydrogen peroxide in topoisomerase inhibitor β-lapachone-induced apoptosis and differentiation in human leukemia cells. Free Radic. Biol. Med. 24:1998;660-670.
14. Lawrence M.S., Ho D.Y., Sun G.H., Steinberg G.K., Sapolsky R.M. Overexpression of Bcl-2 with herpes simplex virus vectors protects CNS neurons against neurological insults in vitro and in vivo. J. Neurosci. 16:1996;486-496.
15. Bruce-Keller A.J., Begley J.G., Fu W., Butterfield D.A., Bredesen D.E., Hutchins J.B., Hensley K., Mattson M.P. Bcl-2 protects isolated plasma and mitochondrial membranes against lipid peroxidation induced by hydrogen peroxide and amyloid β-peptide. J. Neurochem. 70:1998;31-39.
16. Fabisiak J.P., Kagan V.E., Ritov V.B., Johnson D.E., Lazo J.S. Bcl-2 inhibits selective oxidation and externalization of phosphatidylserine during paraquat-induced apoptosis. Am. J. Physiol. 272:1997;C675-C684.
17. Myers K.M., Fiskum G., Liu Y., Simmens S.J., Bredesen D.E., Murphy A.N. Bcl-2 protects neural cells from cyanide/aglycemia-induced lipid oxidation, mitochondrial injury, and loss of viability. J. Neurochem. 65:1995;2432-2440.
18. Gangmin D., Joseph H.S., Kathryn J.I., Ben V.H., Carl W.C. Bcl-2 facilitates recovery from DNA damage after oxidative stress. Exp. Neurol. 159:1999;309-318.
19. 2. Exp. Eye Res. 74:2002;663-669.
20. Liu Y., Naumovski L., Hanawalt P. Nucleotide excision repair capacity is attenuated in human promyelocytic HL60 cells that overexpress BCL2. Cancer Res. 57:1997;1650-1653.
21. Lee M., Hyun D.H., Halliwell B., Jenner P. Effect of overexpression of wild-type and mutant Cu/Zn-superoxide dismutases on oxidative stress and cell death induced by hydrogen peroxide, 4-hydroxynonenal or serum deprivation: potentiation of injury by ALS-related mutant superoxide dismutases and protection by Bcl-2. J. Neurochem. 78:2001;209-220.
22. Curtin J.F., Donovan M., Cotter T.G. Regulation and measurement of oxidative stress in apoptosis. J. Immunol. Methods. 265:2002;49-72.
23. Davis J.B. Oxidative mechanisms in beta-amyloid cytotoxicity. Neurodegeneration. 5:1996;441-444.
24. Ellerby L.M., Ellerby H.M., Park S.M., Holleran A.L., Murphy A.N., Fiskum G., Kane D.J., Testa M.P., Kayalar C., Bredesen D.E. Shift of the cellular oxidation-reduction potential in neural cells expressing Bcl-2. J. Neurochem. 67:1996;1259-1267.
25. Papadopoulos M.C., Koumenis I.L., Xu L., Giffard R.G. Potentiation of murine astrocyte antioxidant defence by bcl-2: protection in part reflects elevated glutathione levels. Eur. J. Neurosci. 10:1998;1252-1260.
26. Lee M., Hyun D.H., Marshall K.A., Ellerby L.M., Bredesen D.E., Jenner P., Halliwell B. Effect of overexpression of BCL-2 on cellular oxidative damage, nitric oxide production, antioxidant defenses, and the proteosome. Free Radic. Biol. Med. 31:2001;1550-1559.
27. Hochman A., Sternin H., Gorodin S., Korsmeyer S., Ziv I., Melamed E., Offen D. Enhanced oxidative stress and altered antioxidants in brains of Bcl-2-deficient mice. J. Neurochem. 71:1998;741-748.
28. Merad-Saidoune M., Boitier E., Nicole A., Marsac C., Martinou J.C., Sola B., Sinet P.M., Ceballos-Picot I. Overproduction of Cu/Zn-superoxide dismutase or Bcl-2 prevents the brain mitochondrial respiratory dysfunction induced by glutathione depletion. Exp. Neurol. 158:1999;428-436.
29. Huang T.T., Yasunami M., Carlson E.J., Gillespie A.M., Reaume A.G., Hoffman E.K., Chan P.H., Scott R.W., Epstein C.J. Superoxide-mediated cytotoxicity in superoxide dismutase-deficient fetal fibroblasts. Arch. Biochem. Biophys. 344:1997;424-432.
30. Lu S.C. Regulation of hepatic glutathione synthesis: current concepts and controversies. FASEB J. 13:1999;1169-1183.
31. Voehringer D.W. BCL-2 and glutathione: alterations in cellular redox state that regulate apoptosis sensitivity. Free Radic. Biol. Med. 27:1999;945-950.
32. Voehringer D.W., McConkey D.J., McDonnell T.J., Brisbay S., Meyn R.E. Bcl-2 expression causes redistribution of glutathione to the nucleus. Proc. Natl. Acad. Sci. U.S.A. 95:1998;2956-2960.
33. Toledano M.B., Kullik I., Trinh F., Baird P.T., Schneider T.D., Storz G. Redox-dependent shift of OxyR-DNA contacts along an extended DNA-binding site: a mechanism for differential promoter selection. Cell. 78:1994;897-909.
34. Voehringer D.W., Hirschberg D.L., Xiao J., Lu Q., Roederer M., Lock C.B., Herzenberg L.A., Steinman L., Herzenberg L.A. Gene microarray identification of redox and mitochondrial elements that control resistance or sensitivity to apoptosis. Proc. Natl. Acad. Sci. U.S.A. 97:2000;2680-2685.
35. Rahman I., MacNee W. Regulation of redox glutathione levels and gene transcription in lung inflammation: therapeutic approaches. Free Radic. Biol. Med. 28:2000;1405-1420.
36. Sen C.K., Packer L. Antioxidant and redox regulation of gene transcription. FASEB J. 10:1996;709-720.
37. Martindale J.L., Holbrook N.J. Cellular response to oxidative stress: signaling for suicide and survival. J. Cell Physiol. 192:2002;1-15.
38. Patrick A.B., Thomas H. Function and activation of NF-κB in the immune system. Annu. Rev. Immunol. 12:1994;141-179.
39. Christman J.W., Blackwell T.S., Juurlink B.H. Redox regulation of nuclear factor kappa B: therapeutic potential for attenuating inflammatory responses. Brain Pathol. 10:2000;153-162.
40. Schoonbroodt S., Piette J. Oxidative stress interference with nuclear factor-kappa B activation pathways. Biochem. Pharmacol. 60:2000;1075-1083.
41. Wang T., Zhang X., Li J.J. The role of NF-κB in the regulation of cell stress responses. Int. J. Immunopharmacol. 2:2002;1509-1520.
42. Ginn-Pease M.E., Whisler R.L. Redox signals and NF-κB activation in T cells. Free Radic. Biol. Med. 25:1998;346-361.
43. Kaltschnidt B. Activation of NF-κB by reactive oxygen intermediates in the nervous system. Antioxid. Redox Signal. 1:1999;129-144.
44. Foo S.Y., Nolan G.P. NF-κB to the rescue: RELs, apoptosis and cellular transformation. Trends Genet. 15:1999;229-235.
45. Lezoualc'h F., Sagara Y., Holsboer F., Behl C. High constitutive NF-κB activity mediates resistance to oxidative stress in neuronal cells. Neuroscience. 18:1998;3224-3232.
46. Taglialatela G., Robinson R., Perez-Polo J.R. Inhibition of nuclear factor κB (NFκB) activity induces nerve growth factor-resistant apoptosis in PC12 cells. J. Neurosci. Res. 47:1997;155-162.
47. Mitsiades N., Mitsiades C.S., Poulaki V., Chauhan D., Richardson P., Hideshima T., Munshi N., Treon S.P., Anderson K.C. Biologic sequelae of nuclear factor-κB blockade in multiple myeloma: therapeutic applications. Blood. 99:2002;4079-4086.
48. Zhou L.Z., Johnson A.P., Rando T.A. NF κB and AP-1 mediate transcriptional responses to oxidative stress in skeletal muscle cells. Free Radic. Biol. Med. 31:2001;1405-1416.
49. Kim H.T., Kim Y.H., Nam J.W., Lee H.J., Rho H.M., Jung G. Study of 5′-flanking region of human Cu/Zn superoxide dismutase. Biochem. Biophys Res. Commun. 201:1994;1526-1533.
50. Jones P.L., Kucera G., Gordon H., Boss J.M. Cloning and characterization of the murine manganous superoxide dismutase-encoding gene. Gene. 153:1995;155-161.
51. Yang H., Wang J., Huang Z.Z., Ou X., Lu S.C. Cloning and characterization of the 5′-flanking region of the rat glutamate-cysteine ligase catalytic subunit. Biochem. J. 357:2001;447-455.
52. Mulcahy R.T., Gipp J.J. Identification of a putative antioxidant response element in the 5′-flanking region of the human gamma-glutamylcysteine synthetase heavy subunit gene. Biochem. Biophys Res. Commun. 209:1995;227-233.
53. Yang H., Wang J., Ou X., Huang Z.Z., Lu S.C. Cloning and analysis of the rat glutamate-cysteine ligase modifier subunit promoter. Biochem. Biophys. Res. Commun. 285:2001;476-482.
54. Urata Y., Yamamoto H., Goto S., Tsushima H., Akazawa S., Yamashita S., Nagataki S., Kondo T. Long exposure to high glucose concentration impairs the responsive expression of gamma-glutamylcysteine synthetase by interleukin-1β and tumor necrosis factor-α in mouse endothelial cells. J. Biol. Chem. 271:1996;15146-15152.
55. de Moissac D., Mustapha S., Greenberg A.H., Kirshenbaum L.A. Bcl-2 activates the transcription factor NFκB through the degradation of the cytoplasmic inhibitor IκB-α J. Biol. Chem. 273:1998;23946-23951.
56. de Moissac D., Zheng H., Kirshenbaum L.A. Linkage of the BH4 domain of Bcl-2 and the nuclear factor κB signaling pathway for suppression of apoptosis. J. Biol. Chem. 274:1999;29505-29509.
57. Regula K.M., Ens K., Kirshenbaum L.A. IKKβ is required for Bcl-2-mediated NF-κB activation in ventricular myocytes. J. Biol. Chem. 77:2002;38676-38682.
58. Ricca A., Biroccio A., Del Bufalo D., Mackay A.R., Santoni A., Cippitelli M. bcl-2 over-expression enhances NF-κB activity and induces mmp-9 transcription in human MCF7(ADR) breast cancer cells. Int. J. Cancer. 86:2000;188-196.
59. Baeuerle P.A., Baltimore D. NF-κB: ten years after. Cell. 87:1996;13-20.
60. Mercurio F., Manning A.M. Multiple signals converging on NF-κB. Curr. Opin. Cell Biol. 11:1999;226-232.
61. Nemoto S., DiDonato J.A., Lin A. Coordinate regulation of IκB kinases by mitogen-activated protein kinase kinase kinase 1 and NF-κB-inducing kinase. Mol. Cell. Biol. 18:1998;7336-7343.
62. Zhao Q., Lee F.S. Mitogen-activated protein kinase/ERK kinase kinases 2 and 3 activate nuclear factor-κB through IκB kinase-α and IκB kinase-β Biol. Chem. 274:1999;8355-8358.
63. Bowie A., O'Neill L.A. Oxidative stress and nuclear factor-κB activation: a reassessment of the evidence in the light of recent discoveries. Biochem. Pharmacol. 59:2000;13-23.
64. Xia Z., Dickens M., Raingeaud J., Davis R.J., Greenberg M.E. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science. 270:1995;1326-1331.
65. Ishikawa Y., Kitamura M. Dual potential of extracellular signal-regulated kinase for the control of cell survival. Biochem. Biophys. Res. Commun. 264:1999;696-701.
66. Chen B.C., Lin W.W. PKC- and ERK-dependent activation of I kappaB kinase by lipopolysaccharide in macrophages: enhancement by P2Y receptor-mediated CaMK activation. Br. J. Pharmacol. 134:2001;1055-1065.
67. Schouten G.J., Vertegaal A.C.O., Whiteside S.T., Israël A., Toebes M., Dorsman J.C., van der Eb A.J., Zantema A. IκB is a target for the mitogen-activated 90 kDa ribosomal S6 kinase. EMBO J. 16:1997;3133-3144.
68. Hsu T.C., Young M.R., Cmarik J., Colburn N.H. Activator protein 1 (AP-1)- and nuclear factor κB (NF-κB)-dependent transcriptional events in carcinogenesis. Free Radic. Biol. Med. 28:2000;1338-1418.
69. Park J.H., Levitt L. Overexpression of mitogen-activated protein kinase (ERK1) enhances T-cell cytokine gene expression: role of AP1, NF-AT, and NF-κB. Blood. 82:1993;2470-2477.
70. Lee F.S., Hagler J., Chen Z.J., Maniatis T. Activation of the IκB alpha kinase complex by MEKK1, a kinase of the JNK pathway. Cell. 88:1997;213-222.
71. Vanden Berghe W., Plaisance S., Boone E., De Bosscher K., Schmitz M.L., Fiers W., Haegeman G. p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways are required for nuclear factor-κB p65 transactivation mediated by tumor necrosis factor. J. Biol. Chem. 273:1998;3285-3290.
72. 2-terminal kinase activity, and apoptosis. Mol. Cell. Biol. 19:1999;5659-5674.